About this trial
The goal of this observational study is to learn about low-grade inflammation in healthy individuals and individuals with overweight or obesity.
The main questions it aims to answer are:
* Whether it is possible to predict low-grade inflammation * What are the medical, biological, and lifestyle variables related to low-grade inflammation?
Participants will be asked to:
1. Attend a general medical visit to collect vital signs, anthropometric measurements, and collect blood samples. 2. Complete questionnaires and collect a stool sample at home.
Eligibility criteria
Qualifiers
Male or female between the ages of 18 and 70 included,
Clinically at-risk group Body Mass Index between 25 (included) and up to 35 kg/m2 (excluded)
Non-clinically at-risk group Body Mass Index between 18.5 (included) and up to 25 kg/m2 (excluded) and absence of metabolic syndrome criteria
Subject covered by social security or a similar system.
Disqualifiers
Rheumatoid arthritis, reactive or psoriatic arthritis (non-osteoarthritis)
Inflammatory bowel disease (IBD) (Crohn's disease or ulcerative colitis) or irritable bowel syndrome
Systemic lupus erythematosus
Uncontrolled psoriasis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Integrative Phenomics
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborator
Assistance Publique Hopitaux De Marseille
Collaborator
University Hospital, Bordeaux
Collaborator
Centre Hospitalier Universitaire Dijon
Collaborator
Institut Pasteur de Lille
Collaborator
Hopitaux Civils de Colmar
Collaborator